Pulse Biosciences, Inc.
NASDAQ:PLSE
Overview | Financials
Company Name | Pulse Biosciences, Inc. |
Symbol | PLSE |
Currency | USD |
Price | 15.19 |
Market Cap | 934,438,673 |
Dividend Yield | 0% |
52-week-range | 4.571 - 22.69 |
Industry | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Robert W. Duggan |
Website | https://www.pulsebiosciences.com |
An error occurred while fetching data.
About Pulse Biosciences, Inc.
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD